These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28840697)

  • 1. [Effect of Psoralea corylifolia in treating fatty liver disease in juvenal mouse by inhibiting hepatic NF-κB activation].
    Zhou LS; Yan SQ; Xiong XL; Huang J; Zhang LL; Tang JQ
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2546-2551. PubMed ID: 28840697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].
    Yao XR; Xia F; Tang WJ; Zhou BJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):56-62. PubMed ID: 28109099
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhou L; Tang J; Xiong X; Dong H; Huang J; Zhou S; Zhang L; Qin H; Yan S
    Front Pharmacol; 2017; 8():876. PubMed ID: 29249967
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Buyang Huanwu Decoction on mRNA Expressions of Aorta Rho Kinase and NF-κB p65 in Atherosclerosis Model Rats].
    Zhang HZ; Li L; Jiao R; Zhang Y; Qian Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Dec; 35(12):1495-500. PubMed ID: 26882614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway.
    Zhao J; Zheng H; Liu Y; Lin J; Zhong X; Xu W; Hong Z; Peng J
    Int J Mol Med; 2013 Apr; 31(4):931-7. PubMed ID: 23426790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of curcumol on liver function and fibrosis in rats of nonalcoholic fatty liver disease and its mechanism].
    Qi SY; Huang H; Li YK; Pei LG; Zhang WJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):611-615. PubMed ID: 34821093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
    Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development.
    Chen Z; Liu F; Zheng N; Guo M; Bao L; Zhan Y; Zhang M; Zhao Y; Guo W; Ding G
    Biomed Pharmacother; 2019 Feb; 110():285-293. PubMed ID: 30522014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of soothing liver and invigorating spleen recipes on NF-kappaB signal pathway related genes and proteins in primary hepatocytes of rats with NASH].
    Yang QH; Xu YJ; Feng GF; Yang XS; Han L; Zhang YP; Wang H
    Zhong Yao Cai; 2013 Sep; 36(9):1469-76. PubMed ID: 24620695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of JAZF1 over-expression on high-fat diet-induced non-alcoholic fatty liver disease].
    Hu WJ; Shen WW; Li XJ; Yao J; Jia YJ; Fan XY
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):596-600. PubMed ID: 27788707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of electroacupuncture on inflammatory response of cardiac muscle tissue in mice with acute myocardial ischemia].
    Wang J; Yuan J; Cai Y; Fu S; Li M; Hong H; Lu S; Zhu B
    Zhongguo Zhen Jiu; 2018 May; 38(5):5133-8. PubMed ID: 29797917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice.
    Seo E; Oh YS; Jun HS
    Nutrients; 2016 Feb; 8(2):83. PubMed ID: 26861390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
    Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
    Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.